<DOC>
	<DOCNO>NCT00609466</DOCNO>
	<brief_summary>The main objective trial demonstrate efficacy safety multiple-dose application oral application CG5503 IR 75mg compare placebo ass safety tolerability CG5503 IR 75mg subject follow bunionectomy . This trial perform base previously perform double-blind , placebo-controlled , multiple-dose trial indication investigate 3 dose strength CG5503 IR ( 50 , 75 100 mg ) publish PMID : 18851776 .</brief_summary>
	<brief_title>A Trial Evaluate CG5503 Efficacy Safety Acute Pain After Bunionectomy</brief_title>
	<detailed_description>Subjects undergo bunionectomy often experience moderate severe acute pain post-surgery . Normally pain controlled subject receive repeat dos opioid analgesic . However , opioid therapy commonly associate side effect nausea , vomit , sedation , constipation , addiction , tolerance , respiratory depression . CG5503 , newly synthesize drug immediate release ( IR ) formulation , also act centrally act pain reliever dual mode action . The aim trial investigate effectiveness ( level pain control ) safety ( side effect ) CG5503 IR 75mg compare drug ( placebo ) one dose morphine ( opioid commonly use treat post-surgical pain ) . This trial randomize , double-blind ( neither investigator patient know treatment receive ) , active- placebo-controlled , parallel-group , multicenter trial evaluate treatment acute pain bunionectomy . The trial include blind 72 hour inpatient phase immediately follow bunionectomy , subject treat either 75-mg CG5503 IR , placebo , 30-mg morphine , pain relief periodically assess . Assessments pain relief include pain intensity numeric rating scale ( PI ) , pain relief numeric rating scale ( PAR ) , patient global impression change scale ( PGIC ) . Safety evaluation include monitor adverse event , physical examination , clinical laboratory test . Venous blood sample collect determination serum concentration CG5503 morphine . The alternative trial hypothesis least 1 dose strength CG5503 different placebo control pain 48 hour .</detailed_description>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Acute Pain</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>Male female subject 18 80 year age ; Scheduled undergo primary unilateral first metatarsal bunionectomy ; Anesthesiological surgical procedure perform accord protocol ; Moderate severe baseline pain follow bunionectomy VRS within 9 hour termination continuous popliteal sciatic block systemic analgesia ; Pain follow bunionectomy least 4 11point NRS within 9 hour termination continuous popliteal sciatic block systemic analgesia ; American Society Anesthesiologists ( ASA ) classification IIII . History seizure disorder ; History alcohol , medication drug dependency , unstable psychological personality require intermittent permanent treatment ; severely impair renal function , moderately severely impaired hepatic function ; Contraindications , history allergy hypersensitivity CG5503 , oxycodone , morphine , fentanyl hydrocodone , acetaminophen , heparin , compound plan used anesthesia , excipients ; Preoperative use within 12h prior surgery perioperative use non steroidal antiinflammatory drug ( NSAIDs ) ; Treated regularly opioid analgesic NSAIDs within 30 day prior screen ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Opioid</keyword>
	<keyword>Central act analgesic</keyword>
	<keyword>CG5503 IR</keyword>
	<keyword>Postoperative pain</keyword>
	<keyword>Bunionectomy</keyword>
	<keyword>Morphine</keyword>
	<keyword>Placebo</keyword>
</DOC>